| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Randall C Schatzman last filed a Form 4 in March 2024, as Chief Executive Officer at BOLT. Randall C Schatzman's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 1,500 shares of BOLT. Net of sales, the BOLT filings show accumulation of 1,500 shares.
Randall C Schatzman has 5 Form 4 filings on record from February 2021 to March 2024, all as Chief Executive Officer at Bolt Biotherapeutics (BOLT), 2021–2024.
The 5 reported transactions were 4 option or other derivative awards and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $30K and no sales.
The only open-market purchase was 1,500 shares of BOLT at an average $20.00 on February 9, 2021, about $30K.
Shares as reported in the last Form 4 for each company; the most recent is from March 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2021 | BOLT Bolt Biotherapeutics, Inc. | Chief Executive Officer | Buy | 1,500 | $20.00 | $30,000.00 | New |